Serum neopterin levels in renal cell carcinoma

Pteridines

Volumn 11, Issue 4, 2000, Pages 133-136

  Yoshida, N ^a   Ikemoto, S ^a   Narita, K ^a   Sugimura, K ^a   Wada, S ^a   Yasumoto, R ^a   Nakatani, T ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C Reactive protein (CRP); Neopterin; Renal cell carcinoma (RCC)

Indexed keywords

C REACTIVE PROTEIN; NEOPTERIN;

ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE COURSE; HUMAN; KIDNEY CARCINOMA; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; PRIORITY JOURNAL;

EID: 0034448094     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.2000.11.4.133     Document Type: Article

References (19)

1. Neopterin in clinical practice
2. Immune response-associated production of neopterin: Release from macrophages primarily under control of interferon-gamma
3. Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection
4. Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis
5. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus
6. Neopterin as a new biochemical marker in the clinical monitoring of bone marrow transplant recipients
7. Posttransplant neopterin excretion in renal allograft recipients: Reliable diagnostic aid of acute rejection and predictive marker of long-term survival
8. Neopterin as a marker for activated cell-mediated immunity: Application in malignant disease
9. Immune status and immune therapy of renal cell carcinoma
10. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix
11. Serum levels of neopterin as related to the prognosis of human prostatic carcinoma
12. The prognostic value of nuclear roundness and neopterin in ovarian cancer
13. Neopterin and prognosis in patients with adenocarcinoma of the colon
14. Predictive value of urinary neopterin in patients with lung cancer
15. Neopterin is an independent prognostic variable in females with breast cancer
16. Significant prognostic factors for 5-year survival after curative resection of renal cell carcinoma
17. Pretreatment serum markers and lymphocytes respond to interleukin-2 therapy
18. Interleukin-6 functions as an in vitro autocrine growth factor in renal cell carcinomas
19. Neopterin derivatives together with cyclic guanosine monophosphate induce c-fos gene expression